Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -1.76M | -448.8% | $ 391.24K |
3/31/2025 | $ -1.88M | -368.98% | $ 508.38K |
12/31/2024 | $ -1.81M | -355.02% | $ 509.59K |
9/30/2024 | $ -1.79M | -352.11% | $ 509.79K |
6/30/2024 | $ -3.33M | -2438.23% | $ 136.4K |
3/31/2024 | $ -3.21M | -12661.64% | $ 25.36K |
12/31/2023 | $ -4.24M | -2778.88% | $ 152.43K |
9/30/2023 | $ -4.22M | -570.5% | $ 739.26K |
6/30/2023 | $ -3.37M | -440.44% | $ 765.64K |
3/31/2023 | $ -5.9M | -550.34% | $ 1.07M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for ABVC BIOPHARMA INC is calculated as follows: CF - Operations [ $ -7.6M ] / Revenues [ $ 355.8K ]
(=) OCF % [ -2135.41% ]
Minimum
Mar 31, 2024
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |